Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
$1.68
-5.6%
$2.05
$1.55
$8.60
$41.24M0.62360,936 shs166,465 shs
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$17.82
+0.9%
$15.74
$9.50
$18.85
$1.61B1.61.22 million shs774,811 shs
Biotech Acquisition stock logo
BIOT
Biotech Acquisition
$10.15
-0.8%
$10.15
$8.30
$10.41
$291.81M-0.12244,605 shs44,400 shs
Thorne HealthTech, Inc. stock logo
THRN
Thorne HealthTech
$10.19
$10.18
$3.41
$10.20
$549.45M0.82110,986 shsN/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
-5.62%-6.67%-23.64%+0.60%-79.03%
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
+0.91%+2.53%+9.73%+28.85%+77.49%
Biotech Acquisition stock logo
BIOT
Biotech Acquisition
0.00%0.00%0.00%0.00%0.00%
Thorne HealthTech, Inc. stock logo
THRN
Thorne HealthTech
0.00%0.00%0.00%0.00%+125.44%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
1.5006 of 5 stars
3.32.00.00.00.03.30.6
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
3.0468 of 5 stars
4.51.00.00.03.41.70.6
Biotech Acquisition stock logo
BIOT
Biotech Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Thorne HealthTech, Inc. stock logo
THRN
Thorne HealthTech
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
2.50
Moderate Buy$24.671,368.25% Upside
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
3.00
Buy$22.5726.66% Upside
Biotech Acquisition stock logo
BIOT
Biotech Acquisition
N/AN/AN/AN/A
Thorne HealthTech, Inc. stock logo
THRN
Thorne HealthTech
2.50
Moderate Buy$8.60-15.60% Downside

Current Analyst Ratings

Latest AVDL, AADI, THRN, and BIOT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/9/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$22.00
3/5/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $22.00
3/5/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$18.00 ➝ $23.00
3/5/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$27.00 ➝ $29.00
3/5/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$21.00 ➝ $25.00
3/5/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $22.00
2/6/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$21.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
$24.35M1.69N/AN/A$4.29 per share0.39
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$27.96M57.73N/AN/A$0.98 per share18.18
Biotech Acquisition stock logo
BIOT
Biotech Acquisition
N/AN/AN/AN/A($0.95) per shareN/A
Thorne HealthTech, Inc. stock logo
THRN
Thorne HealthTech
$228.73M2.40$0.26 per share39.41$2.78 per share3.67

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
-$65.76M-$2.44N/AN/AN/A-270.04%-52.53%-44.29%5/8/2024 (Estimated)
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
-$160.28M-$2.04N/A21.47N/AN/A-198.06%-84.51%5/2/2024 (Estimated)
Biotech Acquisition stock logo
BIOT
Biotech Acquisition
-$6.86MN/A0.00N/AN/A-42.22%3.48%N/A
Thorne HealthTech, Inc. stock logo
THRN
Thorne HealthTech
$15.67M$0.3826.8211.45N/A7.84%9.03%5.57%N/A

Latest AVDL, AADI, THRN, and BIOT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/13/2024Q4 2023
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
-$0.67-$0.60+$0.07-$0.60$6.46 million$6.33 million
3/4/2024Q4 2023
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
-$0.28-$0.32-$0.04-$0.29$17.41 million$19.45 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
N/AN/AN/AN/AN/A
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
N/AN/AN/AN/AN/A
Biotech Acquisition stock logo
BIOT
Biotech Acquisition
N/AN/AN/AN/AN/A
Thorne HealthTech, Inc. stock logo
THRN
Thorne HealthTech
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
N/A
4.72
4.48
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
N/A
3.64
3.36
Biotech Acquisition stock logo
BIOT
Biotech Acquisition
N/A
0.03
0.03
Thorne HealthTech, Inc. stock logo
THRN
Thorne HealthTech
0.16
2.41
1.13

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
52.08%
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
69.19%
Biotech Acquisition stock logo
BIOT
Biotech Acquisition
80.01%
Thorne HealthTech, Inc. stock logo
THRN
Thorne HealthTech
9.48%

Insider Ownership

CompanyInsider Ownership
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
35.80%
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
4.00%
Biotech Acquisition stock logo
BIOT
Biotech Acquisition
19.00%
Thorne HealthTech, Inc. stock logo
THRN
Thorne HealthTech
75.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
8924.55 million15.76 millionOptionable
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
15490.58 million86.95 millionOptionable
Biotech Acquisition stock logo
BIOT
Biotech Acquisition
428.75 million23.29 millionNot Optionable
Thorne HealthTech, Inc. stock logo
THRN
Thorne HealthTech
54453.92 million13.48 millionNot Optionable

AVDL, AADI, THRN, and BIOT Headlines

SourceHeadline
Dr. Gary A. ThorneDr. Gary A. Thorne
health.usnews.com - February 22 at 12:43 PM
Lisa D. ThorneLisa D. Thorne
health.usnews.com - February 3 at 12:57 PM
THORNE HEALTHTECH ANNOUNCES INNOVATION ARM UNDER THORNE VENTURESTHORNE HEALTHTECH ANNOUNCES INNOVATION ARM UNDER THORNE VENTURES
morningstar.com - December 22 at 8:10 PM
Bella Thorne, OnlyFans and the battle over monetising contentBella Thorne, OnlyFans and the battle over monetising content
bbc.com - December 8 at 10:59 PM
Best Redhead OnlyFans Girls Bringing Fire on Only Fans in 2024Best Redhead OnlyFans Girls Bringing Fire on Only Fans in 2024
philadelphiaweekly.com - November 21 at 10:43 AM
Dr. Doris K. ThorneDr. Doris K. Thorne
health.usnews.com - November 17 at 10:05 AM
L Catterton Completes Acquisition of Thorne HealthTech, Inc.L Catterton Completes Acquisition of Thorne HealthTech, Inc.
finance.yahoo.com - October 16 at 10:33 AM
L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender OfferL Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer
finance.yahoo.com - October 13 at 8:26 AM
Evercore ISI Group Downgrades Thorne Healthtech (THRN)Evercore ISI Group Downgrades Thorne Healthtech (THRN)
msn.com - October 11 at 11:42 PM
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Thorne HealthTech, Inc. (THRN)SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Thorne HealthTech, Inc. (THRN)
markets.businessinsider.com - September 20 at 5:01 PM
Should You Be Adding Thorne HealthTech (NASDAQ:THRN) To Your Watchlist Today?Should You Be Adding Thorne HealthTech (NASDAQ:THRN) To Your Watchlist Today?
finance.yahoo.com - September 19 at 9:43 AM
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – THRN,SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – THRN,
bakersfield.com - September 14 at 5:00 PM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thorne HealthTech, Inc. (Nasdaq - THRNBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thorne HealthTech, Inc. (Nasdaq - THRN
bloomberg.com - September 7 at 10:01 AM
TD Cowen Downgrades Thorne Healthtech (THRN)TD Cowen Downgrades Thorne Healthtech (THRN)
msn.com - August 30 at 6:17 PM
THORNE HEALTHTECH INVESTOR ALERT by the Former...THORNE HEALTHTECH INVESTOR ALERT by the Former...
benzinga.com - August 30 at 2:49 AM
Thorne HealthTech IncThorne HealthTech Inc
jp.reuters.com - August 29 at 5:35 AM
Shareholder Alert: Ademi LLP investigates whether Thorne HealthTech, Inc. has obtained a Fair Price in its transaction with L CattertonShareholder Alert: Ademi LLP investigates whether Thorne HealthTech, Inc. has obtained a Fair Price in its transaction with L Catterton
benzinga.com - August 28 at 2:33 PM
Thorne HealthTech Goes Private In $680M Cash Deal With L Catterton; Stock SoarsThorne HealthTech Goes Private In $680M Cash Deal With L Catterton; Stock Soars
msn.com - August 28 at 2:33 PM
Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in CashThorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in Cash
finance.yahoo.com - August 28 at 9:33 AM
Thorne HealthTech trades higher, extending month-long gainsThorne HealthTech trades higher, extending month-long gains
msn.com - August 23 at 7:15 PM
Investing in Thorne HealthTech (NASDAQ:THRN) a year ago would have delivered you a 46% gainInvesting in Thorne HealthTech (NASDAQ:THRN) a year ago would have delivered you a 46% gain
finance.yahoo.com - August 23 at 7:14 PM
TWOU, OTLY and LWAY among mid-day moversTWOU, OTLY and LWAY among mid-day movers
msn.com - August 22 at 4:03 PM
Thorne Launches Global Campaign – Build to Last – With Father and Son Duo Dwyane and Zaire WadeThorne Launches Global Campaign – Build to Last – With Father and Son Duo Dwyane and Zaire Wade
blackenterprise.com - August 16 at 3:18 PM
Thorne HealthTech, Inc. 2023 Q2 - Results - Earnings Call PresentationThorne HealthTech, Inc. 2023 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 12 at 11:54 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aadi Bioscience logo

Aadi Bioscience

NASDAQ:AADI
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Avadel Pharmaceuticals logo

Avadel Pharmaceuticals

NASDAQ:AVDL
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Biotech Acquisition logo

Biotech Acquisition

NASDAQ:BIOT
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Thorne HealthTech logo

Thorne HealthTech

NASDAQ:THRN
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.